Omada Health CEO sells 21,572 shares after option exercise
Omada Health, Inc. (OMDA) reported that Chief Executive Officer and director Sean P. Duffy exercised previously vested stock options and sold shares on September 1, 2026 under a Rule 10b5-1 trading plan adopted on March 13, 2026.
Rhea-AI Filing Summary
Omada Health, Inc. (OMDA) reported that Chief Executive Officer and director Sean P. Duffy exercised previously vested stock options and sold shares on September 1, 2026 under a Rule 10b5-1 trading plan adopted on March 13, 2026. He exercised options covering 21,572 shares of common stock at exercise prices of $5.82, $8.28, and $9.18 per share, receiving an equal number of common shares. On the same date he sold a total of 21,572 shares of common stock in market transactions at weighted average prices between roughly $22.69 and $24.56 per share, and an additional 9,885 shares of common stock were delivered or withheld to cover the option exercise price or related tax liability. Following these transactions, an entity associated with him holds 851,659 shares of common stock indirectly through family trusts, for which he disclaims beneficial ownership except to the extent of his pecuniary interest.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Exercise and Sale: 21,572 shares ($359K approx. pre-tax spread)
Exercise and Sale
12 txns
Insider
Duffy Sean P.
Role
Chief Executive Officer
Sold
21,572 shs ($509K)
Approx. gross sale proceeds
$509K
Approx. exercise cost
$151K
Approx. pre-tax spread
$359K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) F7 | 12,944 | $0.00 | $0.00 |
| Exercise | Stock Option (Right to Buy) F7 | 4,314 | $0.00 | $0.00 |
| Exercise | Stock Option (Right to Buy) F7 | 4,314 | $0.00 | $0.00 |
| Exercise | Common Stock F1 | 12,944 | $5.82 | $75K |
| Exercise | Common Stock F1 | 4,314 | $8.28 | $36K |
| Exercise | Common Stock F1 | 4,314 | $9.18 | $40K |
| Sale | Common Stock F1, F2 | 7,344 | $23.1184 | $170K |
| Sale | Common Stock F1, F3 | 5,600 | $24.268 | $136K |
| Sale | Common Stock F1, F4 | 4,933 | $23.13 | $114K |
| Sale | Common Stock F1, F5 | 3,695 | $24.2713 | $90K |
| Exercise Price or Tax Liability | Common Stock | 9,885 | $22.84 | $226K |
| holding | Common Stock F6 | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 748,751 contracts (Direct);
Common Stock — 401,976 shares (Direct);
Common Stock — 851,659 shares (Indirect, See footnote)
Footnotes (7)
- F1. Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.
- F2. This transaction was executed in multiple trades at prices ranging from $22.69 to $23.60. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F3. This transaction was executed in multiple trades at prices ranging from $23.75 to $24.55. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4. This transaction was executed in multiple trades at prices ranging from $22.71 to $23.60. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F5. This transaction was executed in multiple trades at prices ranging from $23.76 to $24.56. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F6. Held in family trusts for the benefit of the Reporting Person's family members. The Reporting Person disclaims beneficial ownership of the shares held by the family trusts except to the extent of his pecuniary interest therein.
- F7. 100% of the shares subject to the option are fully vested and exercisable.
Key Figures
Options exercised: 21,572 shares
Shares sold: 21,572 shares
Exercise prices: $5.82, $8.28, $9.18 per share
+4 more
7 metrics
Options exercised
21,572 shares
Total options exercised by Sean P. Duffy on September 1, 2026
Shares sold
21,572 shares
Total Omada Health common shares sold on September 1, 2026
Exercise prices
$5.82, $8.28, $9.18 per share
Exercise prices for the three option blocks exercised
Sale price ranges
$22.69–$24.56 per share
Weighted-average price ranges for the reported stock sales
Shares used for exercise price or taxes
9,885 shares
Common shares delivered or withheld to cover option exercise price or tax liability
Indirectly held shares
851,659 shares
Common shares held indirectly through family trusts after the reported transactions
Trading plan adoption date
March 13, 2026
Date Sean P. Duffy adopted the Rule 10b5-1 trading plan used for these trades
Key Terms
Rule 10b5-1 trading plan, weighted average price, pecuniary interest, family trusts
4 terms
Rule 10b5-1 trading plan regulatory
"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The price reported above reflects the weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
pecuniary interest financial
"except to the extent of his pecuniary interest therein."
family trusts financial
"Held in family trusts for the benefit of the Reporting Person's family members."
FAQ
What did OMDA’s CEO Sean P. Duffy report on this Form 4?
He reported exercising stock options for 21,572 shares of Omada Health common stock and selling 21,572 shares of common stock on September 1, 2026, along with 9,885 shares delivered or withheld to cover the option exercise price or related tax liability.
Were the OMDA Form 4 transactions made under a Rule 10b5-1 trading plan?
Yes. A footnote states the transactions were made pursuant to a Rule 10b5-1 trading plan adopted by Sean P. Duffy on March 13, 2026, indicating the trades followed a pre-established plan.
What option exercises did OMDA’s CEO report on September 1, 2026?
He exercised fully vested options for 12,944 shares at $5.82 per share, 4,314 shares at $8.28 per share, and 4,314 shares at $9.18 per share, receiving an equal number of Omada Health common shares in each case.
At what prices did Sean P. Duffy sell OMDA common stock?
He sold 21,572 shares of Omada Health common stock in multiple trades at weighted average prices, with ranges disclosed as $22.69–$23.60, $23.75–$24.55, $22.71–$23.60, and $23.76–$24.56 per share.
AI-generated analysis. How Rhea-AI works. Not financial advice.
